Figure 3: Palmitate lipid treatments alter Nav1.5 palmitoylation in HEK293 cells that stably express Nav1.5. | Nature Communications

Figure 3: Palmitate lipid treatments alter Nav1.5 palmitoylation in HEK293 cells that stably express Nav1.5.

From: Cardiac sodium channel palmitoylation regulates channel availability and myocyte excitability with implications for arrhythmia generation

Figure 3

The results are representative of at least three independent experiments. (a) 2-Br-palmitate(2BP) treatment inhibited Nav1.5 palmitoylation at 25 μM. (b) Palmitic acid(PA) treatment increased Nav1.5 palmitoylation at 10 μM.

Back to article page